# CD34+ Transplants for Leukemia and Lymphoma

> **NCT05565105** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Guenther Koehne** · enrollment: 100 (estimated)

## Conditions studied

- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute

## Interventions

- **RADIATION:** Total Body Irradiation (TBI)
- **DRUG:** Thiotepa
- **DRUG:** Cyclophosphamide
- **DRUG:** Busulfan
- **DRUG:** Melphalan
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT05565105
- **Lead sponsor:** Guenther Koehne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2033-06
- **Final completion:** 2033-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05565105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05565105, "CD34+ Transplants for Leukemia and Lymphoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05565105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*